Lataa...
A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug l-asparaginase
l-Asparaginase is a key therapeutic agent for treatment of childhood acute lymphoblastic leukemia (ALL). There is wide individual variation in pharmacokinetics, and little is known about its metabolism. The mechanisms of therapeutic failure with l-asparaginase remain speculative. Here, we now report...
Tallennettuna:
Päätekijät: | , , , , , , , , , , , , , , , , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
American Society for Clinical Investigation
2009
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2701869/ https://ncbi.nlm.nih.gov/pubmed/19509471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI37977 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|